These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 37114853

  • 61. Efficacy and tolerability of perampanel in pediatric patients with Dravet syndrome.
    Yoshitomi S, Takahashi Y, Yamaguchi T, Imai K, Ishii A, Hirose S, Inoue Y.
    Epilepsy Res; 2019 Aug; 154():34-38. PubMed ID: 31035242
    [Abstract] [Full Text] [Related]

  • 62. Two-year efficacy of lacosamide as adjunctive therapy for generalized tonic-clonic seizures in patients with juvenile myoclonic epilepsy.
    Kobayashi Y, Honda R, Yamada K, Hojo M, Miura M, Seki E, Ono T, Tohyama J.
    Brain Dev; 2023 Sep; 45(8):451-455. PubMed ID: 37308336
    [Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. Perampanel, an AMPA receptor antagonist: From clinical research to practice in clinical settings.
    Tsai JJ, Wu T, Leung H, Desudchit T, Tiamkao S, Lim KS, Dash A.
    Acta Neurol Scand; 2018 Apr; 137(4):378-391. PubMed ID: 29214650
    [Abstract] [Full Text] [Related]

  • 70. The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a "real world" context: focus on temporal lobe epilepsy.
    Pascarella A, Iannone LF, Di Gennaro G, D'Aniello A, Ferlazzo E, Gagliostro N, Ursini F, Bonanni P, Paciello N, Romigi A, Aguglia U, De Sarro G, Russo E, Gambardella A, Labate A.
    J Neurol Sci; 2020 Aug 15; 415():116903. PubMed ID: 32447055
    [Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. Real-world evaluation of perampanel effectiveness in Japanese adolescents with epilepsy.
    Inoue Y, Sumitomo K, Matsutani K, Ishii M.
    Epileptic Disord; 2022 Oct 01; 24(5):813-821. PubMed ID: 35792849
    [Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76. Low-dose sodium valproate in the treatment of idiopathic generalized epilepsies.
    Miró J, Aiguabella M, Veciana M, Juvany R, Santurino M, Leiva E, Salas-Puig J, Falip M.
    Acta Neurol Scand; 2014 May 01; 129(5):e20-3. PubMed ID: 24372179
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305.
    French JA, Krauss GL, Steinhoff BJ, Squillacote D, Yang H, Kumar D, Laurenza A.
    Epilepsia; 2013 Jan 01; 54(1):117-25. PubMed ID: 22905857
    [Abstract] [Full Text] [Related]

  • 79. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV, Valencia I, Khurana DS, Hardison H, Melvin JJ, Legido A.
    Epileptic Disord; 2004 Dec 01; 6(4):267-70. PubMed ID: 15634623
    [Abstract] [Full Text] [Related]

  • 80. Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON).
    Abril Jaramillo J, Estévez María JC, Girón Úbeda JM, Vega López Ó, Calzado Rivas ME, Pérez Díaz H, García Martín G, Vila Herrero E, Chamorro-Muñoz M, Vázquez F, De la Fuente C, Redondo L, Peláez N, Santágueda P, Rodríguez Uranga JJ.
    Epilepsy Behav; 2020 Jan 01; 102():106655. PubMed ID: 31812902
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.